UK markets closed

NIKKEI 225
38,946.93
-122.75(-0.31%)
HANG SENG
19,220.62
-415.60(-2.12%)
CRUDE OIL
78.65
-1.15(-1.44%)
GOLD FUTURES
2,423.90
-14.60(-0.60%)
DOW
39,828.42
+21.65(+0.05%)
Bitcoin GBP
55,012.86
+1,877.34(+3.53%)

What pension research reveals about retirement planning

As the cost of living crisis eases, what steps are you taking to build your pension?

Clinuvel Pharmaceuticals Limited (CLVLF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

10.00

+0.23

(+2.41%)

As of 09:33AM EDT. Market open.

Loading interactive chart…

Simply Wall St.
Is Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Clinuvel Pharmaceuticals' (ASX:CUV) stock is up by a considerable 8.7% over the past month. Since the market usually...
GlobeNewswire
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE® (afamelanotide) and the future of photomedicine. Over 70 guests discussed the Company’s unique history and future growth potential at an invitation-only event in Düsseldorf. Managing Director and CEO, Dr Philippe Wolgen shared the Company’s success in establishing profitability over the past seven financial years
Simply Wall St.
Clinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 50% loss from investing in the stock three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Clinuvel Pharmaceuticals...